Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
Xu Chen, Jingtong Zhang, Weimei Ruan, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6278-6289
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 89
Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients
Hualin Chen, Wenjie Yang, Yingjie Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 75
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
Ming Huang, Wen Dong, Ruihui Xie, et al.
Cancer Communications (2022) Vol. 42, Iss. 5, pp. 447-470
Open Access | Times Cited: 69
Urine biomarkers in bladder cancer — current status and future perspectives
Moritz Maas, Tilman Todenhöfer, Peter C. Black
Nature Reviews Urology (2023) Vol. 20, Iss. 10, pp. 597-614
Closed Access | Times Cited: 59
EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance
Wenjie Wei, Kan Liu, Xing Huang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 20
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study
Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, et al.
PLoS Medicine (2021) Vol. 18, Iss. 8, pp. e1003732-e1003732
Open Access | Times Cited: 68
5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
Jiao Hu, Belaydi Othmane, Anze Yu, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 59
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
Jingtong Zhang, Qianghua Zhou, Keji Xie, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 58
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Joe Ibrahim, Marc Peeters, Guy Van Camp, et al.
European Journal of Cancer (2022) Vol. 178, pp. 91-113
Closed Access | Times Cited: 45
Advances in Diagnosis and Therapy for Bladder Cancer
Xinzi Hu, Guangzhi Li, Song Wu
Cancers (2022) Vol. 14, Iss. 13, pp. 3181-3181
Open Access | Times Cited: 41
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
Kyle Rose, Heather L. Huelster, Joshua J. Meeks, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 7, pp. 406-419
Closed Access | Times Cited: 33
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer
Weimei Ruan, Xu Chen, Ming Huang, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy
Sen Liu, Xu Chen, Tianxin Lin
Cancer Letters (2021) Vol. 505, pp. 13-23
Closed Access | Times Cited: 51
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer
Qianghua Zhou, Xu Chen, Haixia He, et al.
Theranostics (2021) Vol. 11, Iss. 10, pp. 4809-4824
Open Access | Times Cited: 51
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
Sen Liu, Xu Chen, Tianxin Lin
Journal of Advanced Research (2021) Vol. 39, pp. 187-202
Open Access | Times Cited: 48
Matrix stiffness regulates macrophage polarization in atherosclerosis
Yin Wang, Ruotong Shi, Ran Zhai, et al.
Pharmacological Research (2022) Vol. 179, pp. 106236-106236
Closed Access | Times Cited: 36
Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions
Weiyi Shen, Jiamin He, Tongyao Hou, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1063-1063
Open Access | Times Cited: 29
A HER2‐targeted Antibody‐Drug Conjugate, RC48‐ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer
Xuwei Hong, Xu Chen, Hongjin Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 17
UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer
Kanghua Xiao, Shengmeng Peng, Junlin Lu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 16
Urinary markers for bladder cancer diagnosis: A review of current status and future challenges
Eisuke Tomiyama, Kazutoshi Fujita, Mamoru Hashimoto, et al.
International Journal of Urology (2023) Vol. 31, Iss. 3, pp. 208-219
Open Access | Times Cited: 16
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
Fangming Wang, Gang Zhang, Tianli Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications
Danielle Benedict Sacdalan, Sami Ul Haq, Benjamin H. Lok
Current Oncology (2024) Vol. 31, Iss. 1, pp. 482-500
Open Access | Times Cited: 6
Development and validation of an artificial intelligence-based model for detecting urothelial carcinoma using urine cytology images: a multicentre, diagnostic study with prospective validation
Shaoxu Wu, Runnan Shen, Guibin Hong, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102566-102566
Open Access | Times Cited: 6
The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling
Zean Li, Qiong Wang, Shirong Peng, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top